Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Cellectis S.A. (CLLS)

« Back to company index

CLLS Chatter Timeline

Stock Ticker for CLLS

Most Active Tweeters for CLLS

UserTweets
@mediasentiment 9
@investor_feed 3
@Tickeron 3
@newsfilterio 2
@stock_titan 2

Recent Tweets for CLLS

crisprtalk @crisprtalk
$CLLS market cap of 180M. Its tough for these non crispr folks.
May 27th 2022, 7:05pm
mediasentiment @mediasentiment
$CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 143
May 26th 2022, 8:05am
mediasentiment @mediasentiment
$CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 142
May 26th 2022, 8:05am
mediasentiment @mediasentiment
$CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 112
May 24th 2022, 8:05am
investor_feed @investor_feed
$CLLS 6-K Cellectis (23 May, 4:46pm) ? Cellectis’ Annual Shareholders’ General Meeting to be Held… https://t.co/OUhR1K36jU
May 23rd 2022, 8:05pm
FastestAlert @FastestAlert
$CLLS Cellectis’ Annual Shareholders’ General Meeting To Be Held on June 28, 2022 Stock News Alerts In Bio
May 23rd 2022, 8:05pm
newsfilterio @newsfilterio
Cellectis' Annual Shareholders' General Meeting to be Held on June 28, 2022 $CLLS https://t.co/qOIfbEyzB0
May 23rd 2022, 8:05pm
StockNewsBot2 @StockNewsBot2
$CLLS Cellectis’ Annual Shareholders’ General Meeting to be Held on June 28, 2022 https://t.co/uglKokWJ8B
May 23rd 2022, 8:05pm
stock_titan @stock_titan
$CLLS Cellectis’ Annual Shareholders’ General Meeting to be Held on June 28, 2022 https://t.co/4qqYQ2vr2d
May 23rd 2022, 8:05pm
KS_signals @KS_signals
$CLLS SEC Filing 6-K filed: [appointed] of the Bylaws, appointed Mr. Donald A. Bergstrom as Observer of the Board o… https://t.co/VjhARo5eSd
May 23rd 2022, 12:05pm
investor_feed @investor_feed
$CLLS 6-K Cellectis (23 May, 7:54am) ? Current report (foreign) https://t.co/nShcLjMdD6 #CLLS #6K #Cellectis #News
May 23rd 2022, 11:05am
Tickeron @Tickeron
$CLLS in Uptrend: Stochastic indicator penetrating overbought zone. View odds for this and other indicators:… https://t.co/W90PGCKTb7
May 22nd 2022, 7:05am
mediasentiment @mediasentiment
$CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 7
May 22nd 2022, 7:05am
ChartMill @ChartMill
When comparing the current price to the book value of $CLLS, it is valued rather cheaply. https://t.co/1Yg6DcfEhW https://t.co/ywfD5FUDfu
May 21st 2022, 11:05pm
ReaderInvest @ReaderInvest
$CLLS Why Cellectis' Shares Rose 22.7% This Week https://t.co/nYfXgQuRZq
May 21st 2022, 1:05pm
Tickeron @Tickeron
$CLLS's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/hklR6Z2Fb2
May 21st 2022, 2:05am
Loreng91044840 @Loreng91044840
$CLLS ~Top analyst price target today ? https://t.co/f0dLbyCNtE
May 20th 2022, 12:05pm
mediasentiment @mediasentiment
$CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 99
May 20th 2022, 8:05am
mediasentiment @mediasentiment
$CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 240
May 19th 2022, 11:05am
Tickeron @Tickeron
$CLLS in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on May 11, 2022. View odds… https://t.co/j9ZpfwyR1Q
May 18th 2022, 9:05pm
MarcJacksonLA @MarcJacksonLA
$CLLS Robert W Baird Upgrades Cellectis To Outperform From Neutral, $10 PT https://t.co/xKruSlBFiq
May 18th 2022, 2:05pm
vtmtrading @vtmtrading
Cellectis upgraded to Outperform at Baird on valuation 'backstop' $CLLS
May 18th 2022, 10:05am
UsMarketNews @UsMarketNews
$CLLS ?upgrade Baird Upgrades Cellectis to Outperform
May 18th 2022, 10:05am
bthefirsttoknow @bthefirsttoknow
First out// $CLLS: Baird Upgrades Cellectis to Outperform https://t.co/B9CaNi5G4R
May 18th 2022, 10:05am
vtmtrading @vtmtrading
Cellectis upgraded to Outperform from Neutral at Baird $CLLS
May 18th 2022, 9:05am
mediasentiment @mediasentiment
$CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 810
May 18th 2022, 5:05am
1stOncology @1stOncology
#Cellectis Presents Research Data on a Novel #Immune Evasive Universal #CAR #TCell at #ASGCT22 $CLLS https://t.co/BSfFE8dfyi
May 17th 2022, 8:05am
newsfilterio @newsfilterio
Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT $CLLS https://t.co/6ZFXLb6UCK
May 16th 2022, 7:05pm
biotechradar_eu @biotechradar_eu
Cellectis $ALCLS $CLLS Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT https://t.co/uHgdn2DjCd
May 16th 2022, 12:05pm
PennyStockNews5 @PennyStockNews5
$CLLS ? Sentiments: title 0.3182 | summary 0.5994 Pre-Price: 3.22 | Bid: 3.11 | Ask: 3.19 Volume: 140,392 https://t.co/HUsxj22GI1
May 16th 2022, 12:05pm
investor_feed @investor_feed
$CLLS 6-K Cellectis (16 May, 8:15am) ? Cellectis Presents Research Data on a Novel Immune-Evasive Universal CA… https://t.co/SyJpzxmiqT
May 16th 2022, 12:05pm
quantisnow @quantisnow
$CLLS ? SEC Form 6-K filed by Cellectis S.A. https://t.co/S0lSMDJnur 45 seconds delayed.
May 16th 2022, 12:05pm
StockNewsBot2 @StockNewsBot2
$CLLS Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT https://t.co/mJd5GEs6xO
May 16th 2022, 12:05pm
stock_titan @stock_titan
$CLLS Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT https://t.co/4SBOgew4o5
May 16th 2022, 12:05pm
moshepeled @moshepeled
? $CLLS ?? ? Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT ? https://t.co/frsa5ZuMJV
May 16th 2022, 12:05pm
mediasentiment @mediasentiment
$CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 54
May 16th 2022, 9:05am
mediasentiment @mediasentiment
$CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 8
May 15th 2022, 7:05am
TheTradingBlvd @TheTradingBlvd
Cellectis S.A.'s (CLLS) CEO Andre Choulika on Q1 2022 Results - Earnings Call Transcript $CLLS https://t.co/Zz87Pumwi2
May 13th 2022, 3:05pm
SeekingAlpha @SeekingAlpha
$CLLS $CMVLF - Cellectis S.A.'s (CLLS) CEO Andre Choulika on Q1 2022 Results - Earnings Call Transcript.… https://t.co/vceCqm3MBd
May 13th 2022, 3:05pm
SparkNewswire @SparkNewswire
$CLLS Barclays Maintains Overweight on Cellectis, Lowers Price Target to $7 https://t.co/0GhAjSPczF
May 13th 2022, 12:05pm
Tickeron @Tickeron
$CLLS enters a Downtrend as Momentum Indicator dropped below the 0 level on April 12, 2022. View odds for this and… https://t.co/Er2G9IwpbL
May 13th 2022, 9:05am
Tickeron @Tickeron
This is amazing! What do you think? $CLLS RSI Indicator left the oversold zone. #CellectisSA #stockmarket #stock… https://t.co/VPO0Z8vp9I
May 13th 2022, 8:05am
Tickeron @Tickeron
$CLLS reports Earnings today. $CLLS enters a Downtrend as Momentum Indicator dropped below the 0 level on April 12,… https://t.co/g82QvaHTbV
May 13th 2022, 2:05am
newsfilterio @newsfilterio
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2022 $CLLS https://t.co/q4pusH2371
May 12th 2022, 9:05pm
KS_signals @KS_signals
$CLLS SEC Filing 6-K filed: [appointed] • On February 10, 2022, Bing C. Wang, PhD, MBA, was appointed as Chief Fina… https://t.co/oc0ApzBMrk
May 12th 2022, 8:05pm
mediasentiment @mediasentiment
$CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1032
May 12th 2022, 8:05pm
mediasentiment @mediasentiment
$CLLS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 177
May 11th 2022, 8:05am
stock_titan @stock_titan
$CLLS Monthly information on share capital and company voting rights https://t.co/zag5ivoQgW
May 10th 2022, 8:05pm
algobotnews @algobotnews
Cellectis participates in a conference call with JMP Securities $CLLS
May 10th 2022, 5:05pm
shortablestocks @shortablestocks
$CLLS is short sale restricted for 2022-05-09. https://t.co/EyglEKty9Y
May 9th 2022, 2:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.